Atom Limbs

The Atom Touch is a bionic arm prosthetic developed by Atom Bodies (formerly Atom Limbs), founded in April 2019 by Tyler Hayes, Doug Satzger, and Eric Monsef, with a team that includes former engineers and executives from Apple, Oculus, Zoox, Baxter, and Neuralink. The device attaches to the user via a sportswear-style vest that distributes the arm's weight across the torso rather than concentrating it at the residual limb, reducing the fatigue and discomfort that causes many amputees to abandon conventional prosthetics after two hours of wear. Atom Touch is designed for four-to-six hours of initial daily use, with a stated goal of all-day wear as the technology matures. The arm uses EMG sensor bands placed on the skin of the residual limb to detect muscle and neural electrical activity, which machine learning algorithms then decode in real time to generate corresponding movement in the prosthetic. The hand contains over 10 motors enabling full individual finger articulation, elbow and wrist rotation, and dozens of touch sensors that deliver haptic feedback—transmitted as vibrations—to allow the user to gauge grip force on delicate or varied objects without visual monitoring. The technology has been tested by BBC reporter Paul Carter, a bilateral amputee, who operated a digital version of the arm by directing residual limb muscle movements. The Atom Touch is intended for upper-limb amputees across civilian, rehabilitation, and occupational contexts. Atom Bodies has also identified non-medical commercial applications in agriculture, factory assembly, and hazardous environment robotics. The company has a publicly reported waitlist of over 11,000 individuals and a pipeline of projected demand exceeding $180 million. The device is priced at approximately $25,000, which the company positions as significantly lower than the $200,000 cost of comparable state-of-the-art myoelectric prosthetics, though the final commercial price has not been confirmed. The company has raised over $7 million across funding rounds and conducted crowdfunding via Wefunder. Atom Touch's non-invasive attachment design, individual finger dexterity via 10+ motors, and haptic feedback system represent a technically differentiated approach compared to conventional prosthetics that offer only basic grip patterns. However, the device has not yet completed FDA clinical trials or received commercial clearance, and it remains in a qualified applicant testing phase as of 2025. The $25,000 price point, while below leading alternatives, remains inaccessible to a significant portion of the amputee population, particularly in lower-income countries or for individuals without insurance coverage. Delivery timelines have shifted from the company's initial 2023 and 2024 targets, indicating that commercialization has taken longer than originally projected.